Merck (MRK) PT Lowered to $145 at RBC Capital

October 12, 2026 5:10 AM EDT Send to a Friend
RBC Capital analyst Trung Huynh lowered the price target on Merck (NYSE: MRK) to $145.00 (from $150.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login